Cvid company information, Employees & Contact Information

More than 27 Million People in the U.S. alone have contracted COVID-19, making the vaccine both increasingly scarce and more valuable than ever before. Deciding between who receives it first and who doesn’t isn’t as clear. In the case of Vaccine distribution, it is paramount to consider a wide variety of indicators— demographics, poverty level, health care access, occupation, ethnicity, predisposed health conditions— in determining the most effective allocation of vaccines. However, vaccine distributors do not have this information readily available at their disposal, and more often than not find themselves basing distribution needs off of one or two of the indicators listed above, instead of a culmination of indicators. For instance, emerging data from the CDC suggest that “severe acute respiratory syndrome coronavirus has disproportionately affected Hispanic communities in the United States.” Additionally, we see more Hispanic people working on the frontline and overall limited healthcare access in these communities. All of which, exponentially increase their chances of both contracting and becoming gravely ill from COVID-19 compared to the general population. Yet, these communities are at a disadvantage, as they receive a substantially lower distribution rate of vaccines. Even more, this data contributes to the trend in which areas with more resources receive the vaccine at disproportionate rates than those in areas with minimal resources. Moreover, it is essential that a more robust model is created to provide both the government and healthcare companies access to this crucial information. Ultimately, allowing them to make more informative and accurate decisions, on a large-scale, regarding distribution needs.